BLOOD-BRAIN-BARRIER CHANGES FOLLOWING INTRACEREBRAL INJECTION OF HUMAN RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA IN THE RAT

被引:34
作者
WRIGHT, JL
MERCHANT, RE
机构
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT ANAT,RICHMOND,VA 23298
[2] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV NEUROSURG,RICHMOND,VA 23298
关键词
RTNF-ALPHA; BLOOD-BRAIN BARRIER; TOXICITY; HISTOPATHOLOGY;
D O I
10.1007/BF01057957
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human recombinant tumor necrosis factor-alpha (rTNF-alpha) was administered to normal Fischer 344 rats by stereotaxic intracerebral (IC) injection. Animals receiving a single injection of either 6 x 10(4) U rTNF-alpha or an equivalent volume of excipient (vehicle) in their right parietal lobe. In order to demonstrate any effects rTNF-alpha might have on the blood-brain barrier (BBB), two studies were conducted, one employing exogenous horseradish peroxidase (HRP, 44 kD) as a tracer of BBB permeability and the other using endogenous IgG (150 kD). Rats given rTNF-alpha showed transitory BBB permeability to HRP by 24 hours post-injection; this BBB compromise was determined to be no longer than 60 hours. In the other study, IgG was seen to cross the BBB by 48 hours post-rTNF-alpha injection. Alternatively, rats injected IC with excipient showed only limited BBB opening as a result of injection-induced trauma. We conclude that human rTNF-alpha, injected IC into normal rats triggers a temporary breakdown in BBB integrity which begins sometimes between 12 and 24 hours post-injection, is large enough to permit macromolecules of at least 150 kD to pass, and resolves by 72 hours post-injection.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 22 条
[1]   INTRACEREBRAL INJECTION OF PROINFLAMMATORY CYTOKINES OR LEUKOCYTE CHEMOTAXINS INDUCES MINIMAL MYELOMONOCYTIC CELL RECRUITMENT TO THE PARENCHYMA OF THE CENTRAL-NERVOUS-SYSTEM [J].
ANDERSSON, PB ;
PERRY, VH ;
GORDON, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (01) :255-259
[2]   ROLE OF CYTOKINES AND PLATELET-ACTIVATING FACTOR IN MICROVASCULAR IMMUNE INJURY [J].
BRAQUET, P ;
HOSFORD, D ;
BRAQUET, M ;
BOURGAIN, R ;
BUSSOLINO, F .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1989, 88 (1-2) :88-100
[3]   TNF AND PLASMODIUM-BERGHEI ANKA-INDUCED CEREBRAL MALARIA [J].
CLARK, IA ;
ILSCHNER, S ;
MACMICKING, JD ;
COWDEN, WB .
IMMUNOLOGY LETTERS, 1990, 25 (1-3) :195-198
[4]  
ELLISON MD, 1990, CANCER RES, V50, P4377
[5]  
ELLISON MD, 1987, CANCER RES, V47, P5765
[6]  
GORDON CR, 1990, ACT NEUR S, V51, P268
[7]   ACUTE EFFECTS OF HUMAN RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA ON THE CEREBRAL VASCULATURE OF THE RAT IN BOTH NORMAL BRAIN AND IN AN EXPERIMENTAL GLIOMA MODEL [J].
KIDO, G ;
WRIGHT, JL ;
MERCHANT, RE .
JOURNAL OF NEURO-ONCOLOGY, 1991, 10 (02) :95-109
[8]   ROLE OF EXTRACELLULAR PROTEINS IN THE DYNAMICS OF VASOGENIC BRAIN EDEMA [J].
KUROIWA, T ;
CAHN, R ;
JUHLER, M ;
GOPING, G ;
CAMPBELL, G ;
KLATZO, I .
ACTA NEUROPATHOLOGICA, 1985, 66 (01) :3-11
[9]   INTRALESIONAL INFUSION OF LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS AND RECOMBINANT INTERLEUKIN-2 (RIL-2) FOR THE TREATMENT OF PATIENTS WITH MALIGNANT BRAIN-TUMOR [J].
MERCHANT, RE ;
MERCHANT, LH ;
COOK, SHS ;
MCVICAR, DW ;
YOUNG, HF .
NEUROSURGERY, 1988, 23 (06) :725-732
[10]  
MERCHANT RE, 1988, CANCER, V62, P665, DOI 10.1002/1097-0142(19880815)62:4<665::AID-CNCR2820620403>3.0.CO